David Novack - Feb 10, 2022 Form 4 Insider Report for DYNAVAX TECHNOLOGIES CORP (DVAX)

Role
President & COO
Signature
David Novack, /s/ Trevor Dutcher, Attorney-in-Fact
Stock symbol
DVAX
Transactions as of
Feb 10, 2022
Transactions value $
$0
Form type
4
Date filed
2/14/2022, 08:16 PM
Previous filing
Nov 2, 2021
Next filing
Mar 4, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DVAX Common Stock Options Exercise +52.5K +119.14% 96.6K Feb 10, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DVAX Restricted Stock Unit Options Exercise +52.5K 0 Feb 10, 2022 Common Stock 52.5K Direct F1
transaction DVAX Stock Option (Right to Buy) Award $0 +150K $0.00 150K Feb 10, 2022 Common Stock 150K $12.74 Direct F2
transaction DVAX Restricted Stock Unit Award +26.5K 26.5K Feb 10, 2022 Common Stock 26.5K Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The RSUs vest upon Issuer's common stock achieving a specified price per share for a specified period.
F2 This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 10, 2022, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.
F3 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022